Xenter, Inc. Appoints Industry Leaders Robert S. Langer, Elazer R. Edelman, David J. Bearss and Mark Stautberg to Board of Directors; Closes $12M Series A
Published: May 07, 2021 -Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health- SALT LAKE CITY--(BUSINESS WIRE)-- Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. The additional members are Robert S. Langer, an Institute Professor at MIT and the most cited...
Source: biospace.com